Multiple mitochondrial DNA deletions and lactic acidosis in an HIV-infected patient under antiretroviral therapy.
Walker
U A
UA
Venhoff
N
N
D000140:Acidosis, Lactic / Q000139:chemically induced*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002460:Cell Line; D004272:DNA, Mitochondrial / Q000235:genetics*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D017384:Sequence Deletion; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004272:DNA, Mitochondrial; D004791:Enzyme Inhibitors; D014635:Valproic Acid; D007213:Indomethacin